| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 3 | |
| #2 | Canada | 3 | |
| #3 | China | 3 | |
| #4 | United States | 3 | |
| #5 | WIPO (World Intellectual Property Organization) | 3 | |
| #6 | EPO (European Patent Office) | 2 | |
| #7 | Greece | 1 | |
| #8 | India | 1 | |
| #9 | Japan | 1 | |
| #10 | Republic of Korea | 1 | |
| #11 | Morocco | 1 | |
| #12 | Mexico | 1 | |
| #13 | Singapore | 1 | |
| #14 | Taiwan | 1 | |
| #15 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Medical technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Microorganisms | |
| #4 | Electrotherapy |
| # | Name | Total Patents |
|---|---|---|
| #1 | Boulikas Teni | 26 |
| #2 | Stathopoulos George | 12 |
| #3 | George Stathopoulos | 1 |
| Publication | Filing date | Title |
|---|---|---|
| JP2017178960A | Improved method for treating cancer by reducing renal toxicity | |
| KR20150088237A | Improved methods for treating cancer with reduced renal toxicity | |
| EP2882420A1 | Improved methods for treating cancer with reduced renal toxicity | |
| US2012183596A1 | Encapsulation of Plasmid DNA (Lipogenes) and Therapeutic Agents with Nuclear Localization Signal/Fusogenic Peptide Conjugates into Targeted Liposome Complexes | |
| AU7542301A | Encapsulation of plasmid DNA (lipogenes<sup>TM</sup>) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes |